Published in Cancer Weekly, May 10th, 2005
Such a test could also differentiate specific types of breast tumors at the molecular level. This differentiation could improve diagnosis, lead to more effective individualized treatments, and provide the ability to monitor therapeutic results in real time.
Their study, presented at the 96th annual American Association for Cancer Research in Anaheim, California, on April 18, 2005, provides new, detailed analysis of seven signature molecular markers found in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.